Safety Efforts in Pediatric Drug Development
от
Conor D. Byrne
Оценок пока нет
Children’s
Формат
Твердый переплет
Страницы
133
Язык
Словенский
Опубликовано
Jun 1, 2009
Издатель
Nova Science Pub Inc
Издание
1
ISBN-10
1607415658
ISBN-13
9781607415657
Описание
This comprehensive exploration delves into the intricacies of pediatric drug development, focusing on the vital safety measures that underpin the process. It highlights the unique challenges faced when researching and testing medications intended for children, whose physiological and psychological differences from adults necessitate a specialized approach. By examining case studies and regulatory frameworks, it reveals how the pharmaceutical industry strives to ensure that drugs are both effective and safe for younger populations.
The narrative also emphasizes the importance of collaboration among researchers, healthcare professionals, and regulatory bodies. It provides insight into the evolving role of regulations that govern safety testing and how these impact the availability of pediatric medications. This collaborative effort is crucial in advancing knowledge and fostering innovation in drug development for children.
Readers will appreciate the blend of scientific rigor with real-world implications, making this an essential resource for anyone involved in pediatric healthcare, drug development, or regulatory science. The discussions set the stage for informed decision-making in an area where patient safety is paramount.
The narrative also emphasizes the importance of collaboration among researchers, healthcare professionals, and regulatory bodies. It provides insight into the evolving role of regulations that govern safety testing and how these impact the availability of pediatric medications. This collaborative effort is crucial in advancing knowledge and fostering innovation in drug development for children.
Readers will appreciate the blend of scientific rigor with real-world implications, making this an essential resource for anyone involved in pediatric healthcare, drug development, or regulatory science. The discussions set the stage for informed decision-making in an area where patient safety is paramount.
Обзоры
Отзывов пока нет
Станьте первым, кто оставит отзыв о этой книге и поделится своими мыслями
Добавить первый отзывЖурнал чтения
Журналы чтения не найдены
Начните отслеживать ваш прогресс в чтении, чтобы видеть записи здесь
Добавьте ваш первый журнал чтенияЗаметки
Журнал транзакций
Журналы транзакций не найдены
Начните отслеживать ваши книжные транзакции, чтобы видеть записи здесь
Добавьте ваш первый журнал транзакций